ROOT Stock Recent News
ROOT LATEST HEADLINES
Let's find out which InsureTech is a safe investment option, ROOT or LMND.
COLUMBUS, Ohio, April 10, 2025 (GLOBE NEWSWIRE) -- Root, Inc. (NASDAQ: ROOT), the parent company of Root Insurance Company, today announced its plans to host a conference call on Wednesday, May 7, 2025 at 5:00 p.m. Eastern Time to discuss financial results for the first quarter 2025 and provide an update on company operations. The company plans to release its first quarter results in the Investor Relations section of its website at ir.joinroot.com following the close of the financial markets on Wednesday, May 7, 2025.
Given the prospects of the Property and Casualty Insurance industry, HRTG, KINS, ROOT and PGR have the potential to generate better returns than other players.
GREENSBORO, N.C. & CHICAGO--(BUSINESS WIRE)--Gilbarco Veeder-Root, a Vontier company and global leader in forecourt solutions, announced today a strategic partnership with W. Capra, a leader in end-to-end consulting to the convenience retail industry. Gilbarco Veeder-Root will be using W. Capra to provide best-in-class technology lab services to support seamless software testing and release cycles, certifications, new product testing, troubleshooting and field rollouts. "We at W. Capra are beyo.
Does Root, Inc. (ROOT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Let us delve deeper to find out what to do with ROOT stock now.
Root (ROOT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for PBGENE-HBV. PBGENE-HBV is Precision's lead wholly owned in vivo gene editing program designed to cure chronic hepatitis B by eliminating c.
Russian President Vladimir Putin thanked U.S. President Donald Trump for giving "so much attention" to the prospect of a Russia-Ukraine deal.
Despite broad market volatility, momentum remains a powerful indicator of future price trends. Over the past month, a few standout stocks have climbed at least 20%, catching the attention of investors looking for sustained upside.